Uganda has begun a trial vaccination programme for the strain of Ebola viral infection that is behind Sudan's latest outbreak, according to the World Health Organization (WHO), while the number of confirmed cases has risen to three.

Ugandan officials initiated a clinical trial on Monday for a vaccine targeting the Sudan strain of Ebola, which has resulted in one fatality since the outbreak was declared last week.

This is a critical achievement toward better pandemic preparedness and saving lives when outbreaks occur,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.

The World Health Organisation (WHO) on Monday said that it has launched a first-ever vaccine trial in Uganda for Ebola from the Sudan species of the virus.In a statement, Dr. Tedros Adhanom Ghebreyesus,

Ugandan officials are preparing to deploy a trial vaccine as part of efforts to stem an outbreak of Ebola in the capital, Kampala

If proven effective, vaccine will further strengthen measures to protect communities from future outbreaks,’ says regional director of world health body - Anadolu Ajansı

In a related development, Ugandan scientists who sequenced the virus said they don't see a link to the country's 2022 outbreak.

Geneva, Switzerland - Uganda on Monday started the first ever vaccination trial for the Sudan species of the Ebola virus four days after an outbreak was

Test results on the sick people are pending, and a top WHO official said the outbreak response is proceeding rapidly.